Dear customer, planned maintenance work will be carried out in our online store on January 11 from 10pm to midnight. For this reason, there may be functional restrictions during this period.
FectoVIR®-AAV is a novel generation of synthetic transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) in both suspension and adherent HEK-293 derivative cell systems
- Item No.:
- 102000006
FectoVIR®-AAV is a novel generation of synthetic transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) in both suspension and adherent HEK-293 derivative cell systems
Overview
Specifications
Choose your Transfection For Viral Vector Manufacturing
FectoVIR®-AAV transfection reagent guarantees higher rAAV titers, improves scalability for large scale production and de-risks manufacturing process with its availability at pharma GMP grade. FectoVIR®-AAV-GMP is manufactured under a validated and aseptic process in compliance with ICH Q7, GMP part II guidelines, the quality grade of reference for active pharmaceutical ingredients (API).
Key Benefits:
- Process Economics: High AAV productivity expands the number of doses per batch to reduce manufacturing costs.
- Industrial Scalability: Designed for large scale with low complexation volume, long complex stability, and high reproducibility.
- GMP Grade Availability: Validated Manufacturing process following ICH Q7 guidelines, provided with full regulatory documentation.
- Risks Mitigation: Both residual test and toxicity statement enable to mitigate risks and ensure patient safety.
Applications
-
ApplicationrAAV (Adeno-Associated Virus) manufacturing using HEK-293 derivative cells
Biological Information
-
Number of transfections1 L of FectoVIR®-AAV transfection reagent is sufficient to transfect on average 500 L of cell culture (using standard conditions)
Compliance Information
-
GMP ComplianceYes
-
OriginAnimal-Component Free
-
Product Documentation
-
Protocol
-
Certificate of Analysis
-
Certificate of origin
-
Non-hazardous product statement
-
Certificate of compliance
-
Drug master file
-
Protocols for identity and activity testing
-
Regulatory support package including toxicity statement
- Quality agreement
-
Protocol
General Specifications
-
Amount of ReagentFectoVIR®-AAV GMP 100 mL Bottle
Storage Conditions
-
Storage Conditions5 °C ± 3 °C